Cholesterol guideline suitability questioned in younger patients with, at risk for MI
The 2018 American College of Cardiology/American Heart Association Guideline on the Management of Blood Cholesterol does not flag most younger patients with premature MI as candidates for stain therapy before their event, researchers found.Source: Healio
Outcomes Similar After TAVR in Bicuspid, Tricuspid Anatomy
All-cause mortality and stroke are comparable at 30 days and one year after transcatheter aortic valve replacement (TAVR) among patients with bicuspid and tricuspid valve stenosis, according to a study published online May 27 in JACC: Cardiovascular Interventions.Source: HealthDay
Opinion: Hydroxychloroquine And Azithromycin For COVID-19: Benefits TBD, Risks Clear
In the midst of a pandemic, lots of people have ideas for cures. We are desperate for therapies and the virus can be deadly. The problem is that the presumptive cure can add danger to the disease, rather than mitigate it.Source: Forbes
Coronavirus infection may cause lasting damage throughout the body, doctors fear
For a world grappling with the new coronavirus, it’s becoming increasingly clear that even when the pandemic is over, it won’t really be over. Now doctors are beginning to worry that for patients who have survived COVID-19, the same may be true.Source: Los Angeles Times
Long Term Results Favor CABG—Is This Surprising?
Ever since the first interventional cardiologist threaded a catheter into an occluded artery in the heart and inflated a balloon to widen the narrowed artery, a turf war has ebbed and flowed between interventionalists and surgeons over the best way to treat CAD.Source: Physicians Weekly
ERs are seeing up to 60% fewer heart attack patients as those infected with coronavirus fill hospital beds but cardiac emergencies mysteriously 'disappear'
Emergency rooms across the U.S. are seeing less than half of usual number of heart attack patients as beds are filled by those infected with coronavirus.Source: Mary Kekatos
Registry data show lower event rates vs. trial data for LAA closure device
Patients with atrial fibrillation who underwent left atrial appendage occlusion with an FDA-approved device had lower rates of major in-hospital adverse events compared with previous trials assessing the device.Source: Healio
Hospitals seeing ‘a previously unimaginable shift’ due to COVID-19—are patients afraid to seek medical attention?
As COVID-19 continues to keep healthcare providers busy, fewer patients appear to be seeking care for other serious issues, including cardiovascular complications such as heart attack and stroke.Source: Cardiovascular Business